期刊文献+

血液病患者血小板减少并发血栓栓塞的中西医辨析 被引量:1

Study on the Thromboembolism of Thrombocytopenia in Hematologic from TCM and Western Medicine
下载PDF
导出
摘要 目的:从现代医学血栓理论及中医血瘀理论,对血液病患者血小板减少并发血栓栓塞患者进行辨析。方法:回顾性分析我院血液科近10年住院患者中血小板减少并发血栓患者的资料,对其生理特征及血栓高危因素加以统计分析。结果:深静脉置管、输血、使用糖皮质激素为血小板减少合并血栓栓塞的高危因素。结论:血液病患者在血小板减少时也极易并发血栓栓塞,在治疗过程中,需时刻警惕血栓的风险。 Objective: To study the thromboembolism of thrombocytopenia in hematologic patients from the theory of thrombosis and blood stasis of TCM. Methods: The data of in-patients hematologic patients with thromboembolism of thrombocytopenia for 10 years, was analyzed. The clinical biological characteristics and the data of related risk factors of complicating thrombosis, were recorded and analyzed. Results: Deep vein catheter, blood transfusion, glucocorticoids were high risk factors for thrombosis. Conclusions: Patients with thrombocytopenia in hematopathy are prone to thromboembolism, so the risk of thrombus should be vigilant In the treatment process.
作者 张文曦 朱欣佚 奚肇庆 孔祥图 代兴斌 于慧 ZHANG Wen-xi;ZHU Xin-yi;XI Zhao-qing;KONG Xiang-tu;DAI Xing-bing;YU hui(The Affiliated Hospital of Nanjing University of Traditional Chinese Medicine,Nanjing Jiangsu 210029,China;Affiliated Zhongda Hospital of Southeast University,Nanjing Jiangsu 210009,China)
出处 《中医药导报》 2019年第5期124-126,共3页 Guiding Journal of Traditional Chinese Medicine and Pharmacy
基金 江苏省中医药局科技项目(FY201501) 江苏省六大人才高峰项目(2015-WSN-055) 江苏高校优势学科建设工程资助项目(苏政办发[2014]37号) 第2批江苏省名老中医药专家奚肇庆传承工作室建设项目(苏中医科教[2016]6号) 第4批全国中医优秀人才研修项目(国中医药人教发[2017]24号)
关键词 血瘀 血栓栓塞 血小板减少 blood stasis thromboembolism thrombocytopenia
  • 相关文献

参考文献7

二级参考文献50

  • 1刘俊伟,袁斌.原发性血小板增多症并急性心肌梗死1例[J].内科急危重症杂志,2005,11(3):106-106. 被引量:2
  • 2闫振宇,华宝来,马西虎,江嘉义,范连凯,王书杰,朱铁楠,白春梅,潘家绮,赵永强.672例静脉血栓栓塞症相关危险因素分析[J].中华血液学杂志,2007,28(9):579-582. 被引量:27
  • 3王兆钺.原发性血小板增多症研究的进展[J].中华血液学杂志,2007,28(9):640-642. 被引量:4
  • 4王兆钺.原发性血小板增多症分子机理与临床研究的进展[J].血栓与止血学,2007,13(5):235-238. 被引量:11
  • 5Leebeek FW,Kruip MJ,Sonneveld P,et al.Risk and management of thrombosis in multiple myeloma.Thromb Res,2012;129 Suppl 1:S88-92.
  • 6Zangari M,Barlogie B,Thertulien R,et al.Thalidomide and deep vein thrombosis in multiple myeloma:risk factors and effect on survival.Clin Lymphoma,2003;4(1):32-35.
  • 7Corso A,Lorenzi A,Terulla V,et al.Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone.Ann Hematol,2004;83(9):588-591.
  • 8Zappasodi P,Mangiacavalli S,Terulla V,et al.Thrombomodulin levels are not modified during thalidomide treatment.Eur J Haematol,2006;77(5):453-454.
  • 9Petropoulou AD,Gerotziafas GT,Samama MM,et al.In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide.Thromb Res,2008;121(4):493-497.
  • 10Streetly M,Hunt BJ,Parmar K,et al.Markers of endothelial and haemostatic function in the treatment of relapsed myeloma with the immunomodulatory agent Actimid(CC-4047)and their relationship with venous thrombosis.Eur J Haematol,2005;74(4):293-296.

共引文献88

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部